Icahn School of Medicine at Mount Sinai (ISMMS)

The Icahn School of Medicine at Mount Sinai (ISMMS), formerly Mount Sinai School of Medicine, is a medical school in New York City, New York.

An off-the-shelf immunotherapy for myeloma called talquetamab is successful in 70 percent of patients

A new type of RNA can inhibit a broad range of viral infections

Could artificial intelligence predict which viruses could infect humans, which animals host them, and where they could emerge from?

A new target for a universal influenza vaccine

Putting cancer cells to sleep to prevent tumor metastasis

Can wearable devices detect Covid-19 symptoms earlier and predict diagnosis?

3D printing of human tissue and eventually entire organs just got 10-50 times faster

Ketamine does help individuals with chronic post-traumatic stress disorder (PTSD)

Turning tumors into cancer vaccine factories

Researchers at Mount Sinai have developed a novel approach to cancer immunotherapy, injecting immune stimulants directly into a tumor to teach the immune system to destroy it and other tumor cells throughout the body. The “in situ vaccination” worked so well in patients with advanced-stage lymphoma that it is also undergoing trials in breast and head

Turning tumors into cancer vaccine factories

New genetic barcoding technology identifies critical cancer immunity genes

Novel gene editing technique reveals cancer weakness in the immune system and opens possibilities to identify disease-causing genes and new drug targets Scientists at Mount Sinai have developed a novel technology for simultaneously analyzing the functions of hundreds of genes with resolution reaching the single cell level. The technology relies on a barcoding approach using

New genetic barcoding technology identifies critical cancer immunity genes

Found: A marker that can indicate whether a breast cancer patient will develop a reoccurrence of lethal metastatic cancer

For the first time ever, Mount Sinai researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a reoccurrence of lethal, metastatic cancer, according to a clinical study published in Breast Cancer Research in October. The researchers found that when cells from a breast cancer patient’s original tumor metastasized into

Found: A marker that can indicate whether a breast cancer patient will develop a reoccurrence of lethal metastatic cancer

Sperm concentration in Western men has declined more than 50 percent in less than 40 years

Meta-analysis finds that among men from North America, Europe and Australia, sperm concentration has declined more than 50 percent in less than 40 years, pointing to impaired male health and decreasing fertility In the first systematic review and meta-analysis of trends in sperm count, researchers from the Hebrew University-Hadassah Braun School of Public Health and

Sperm concentration in Western men has declined more than 50 percent in less than 40 years

Almost 200 Years Later, Are We Living in the Final Days of the Stethoscope

“Certainly the stage is set for disruption” An editorial in this month’s edition of Global Heart (the journal of the World Heart Federation) asks ‘are we living in the final days of the stethoscope’—a question being asked due to the rapid advent of point-of-care ultrasound devices, that are becoming increasingly accurate, smaller to the point

Almost 200 Years Later, Are We Living in the Final Days of the Stethoscope

Vitamin E May Delay Decline in Mild-to-Moderate Alzheimer’s Disease

Study Shows Benefit in Activities of Daily Living and Savings in Caregiver Time with Vitamin E Difficulty with activities of daily living often affect Alzheimer’s patients, which is estimated to affect as many as 5.1 million Americans. These issues are among the most taxing burdens of the disease for caregivers, which total about 5.4 million

Vitamin E May Delay Decline in Mild-to-Moderate Alzheimer’s Disease

Inhalable Gene Therapy May Help Pulmonary Arterial Hypertension Patients

The deadly condition known as pulmonary arterial hypertension (PAH), which afflicts up to 150,000 Americans each year, may be reversible by using an inhalable gene therapy The deadly condition known as pulmonary arterial hypertension (PAH), which afflicts up to 150,000 Americans each year, may be reversible by using an inhalable gene therapy, report an international

Inhalable Gene Therapy May Help Pulmonary Arterial Hypertension Patients

Scientists develop a biodegradable nanoparticle that effectively resolves inflammation

Clearing up inflammation with pro-resolving nanomedicines Inflammation is the body’s natural defense mechanism against invading organisms and tissue injury. In acute inflammation, the pathogen or inflammatory mediators are cleared away and homeostasis is reached, however in chronic inflammatory states, this resolving response is impaired, leading to chronic inflammation and tissue damage. It is now widely

Scientists develop a biodegradable nanoparticle that effectively resolves inflammation

The Latest Bing News on:

Icahn School of Medicine at Mount Sinai (ISMMS) Research

Icahn School of Medicine at Mount Sinai
Do you work at Icahn School of Medicine at Mount Sinai? Manage your school's public image and connection with students using U.S. News Student Connect.
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai is one of more than 800 institutions with graduate schools surveyed by U.S. News on an annual basis. Icahn School of Medicine at Mount Sinai confers degrees ...
Icahn Medical School Wins Cancer Discovery & Development Center Grant
The National Cancer Institute (NCI) awarded the department of immunology and immunotherapy and the Icahn Genomics Institute (IGI) at the Icahn School of Medicine at Mount Sinai, a $5 million grant ...
Mount Sinai bioengineers send cardiac muscle samples into space to study heart cell biology in microgravity
Mount Sinai’s Cardiovascular Research Institute is sending bioengineered human heart muscle cells and micro-tissues into space for the first time on NASA’s 29 th SpaceX commercial resupply ...
The Paul G. Allen Frontiers Group announces Allen Discovery Center for Neuroimmune Interactions at Icahn School of Medicine at Mount Sinai
A multidisciplinary research center to define ... and transform numerous fields of biology and medicine including allergy, autoimmunity, cancer, infection, and metabolism." The Allen Discovery Center ...

The Latest Bing News on:

Icahn School of Medicine at Mount Sinai (ISMMS) Discovery

Mount Sinai Health System names new CEO
The health system's head of emergency medicine, Brendan Carr, will replace the long-standing CEO early next year.
Icahn School of Medicine at Mount Sinai
Do you work at Icahn School of Medicine at Mount Sinai? Manage your school's public image and connection with students using U.S. News Student Connect.
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai is one of more than 800 institutions with graduate schools surveyed by U.S. News on an annual basis. Icahn School of Medicine at Mount Sinai confers degrees ...
Icahn Medical School Wins Cancer Discovery & Development Center Grant
at the Icahn School of Medicine at Mount Sinai, a $5 million grant to establish a center dedicated to the discovery and development of innovative targets for cancer therapy. The new Cancer Target ...
The Paul G. Allen Frontiers Group announces Allen Discovery Center for Neuroimmune Interactions at Icahn School of Medicine at Mount Sinai
and transform numerous fields of biology and medicine including allergy, autoimmunity, cancer, infection, and metabolism." The Allen Discovery Center for Neuroimmune Interactions is funded at $10 ...